Table 1 Reporting of the core outcomes within the rheumatoid arthritis core outcomes set
From: Outcome measures in rheumatoid arthritis randomised trials over the last 50 years
Seven core outcomes (trials <52 weeks) | Eight core outcomes (trials ≥52 weeks) | |||
|---|---|---|---|---|
Intervention classification | % measured (Pre-RA COS) | % measured (Post-RA COS) | % measured (Pre-RA COS) | % measured (Post-RA COS) |
Pharmacological | ||||
DMARD/SAARD | 27 (9/33) | 85 (17/20) | 25 (3/12) | 53 (9/17) |
SMARD | 4 (2/50) | 29 (5/17) | 0 (0/2) | 0 (0/2) |
Glucocorticoids | 100 (1/1) | - | 0 (0/1) | 40 (4/10) |
Biologics | - | 93 (26/28) | - | 64 (7/11) |
Non-pharmacological | ||||
Alternative therapies | 15 (2/13) | 88 (7/8) | 0 (0/2) | 0 (0/2) |
Assistive technology | - | 0 (0/1) | - | - |
Diet | 20 (1/5) | 57 (4/7) | 0 (0/1) | 100 (1/1) |
Exercise | 0 (0/3) | 0 (0/2) | 0 (0/2) | 0 (0/1) |
Rehabilitation | 0 (0/47) | 4 (1/27) | 0 (0/8) | 0 (0/13) |
Surgery | - | - | - | 0 (0/3) |